KIORA PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
KIORA PHARMACEUTICALS, INC. (KPRX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$7.29 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-25
- KIORA PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$7.29M, a 465.38% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $1.99M.
- KIORA PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$9.38M.
- KIORA PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$10.56M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$7.29M 10-K · filed 2026-03-25 | |
| 2024-12-31 | $1.99M 10-K · filed 2026-03-25 | |
| 2023-12-31 | -$9.38M 10-K · filed 2025-03-25 | |
| 2022-12-31 | -$10.56M 10-K · filed 2024-03-25 | |
| 2021-12-31 | -$10.64M 10-K · filed 2023-03-23 | -$13.38M 10-K · filed 2022-04-15 |
| 2020-12-31 | -$6.77M 10-K/A · filed 2022-07-07 | $8.00M 10-K · filed 2021-03-25 |
| 2019-12-31 | $7.52M 10-K · filed 2021-03-25 | |
| 2018-12-31 | $11.24M 10-K · filed 2020-03-04 | |
| 2017-12-31 | $15.10M 10-K · filed 2019-03-01 | -$15.10M 10-K · filed 2018-03-02 |
| 2016-12-31 | -$13.83M 10-K · filed 2018-03-02 | |
| 2015-12-31 | -$8.76M 10-K · filed 2017-02-23 | |
| 2014-12-31 | -$2.00M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |